Welcome to the e-CCO Library!

P196: Major variance in scoring of endoscopic recurrence after ileocolic resection for Crohns Disease – a systematic review and meta-analysis
Year: 2023
Source: ECCO’23 Copenhagen
Authors: Van Der Does De Willebois, E.(1)*;Bellato, V.(2);van Dieren, S.(3);Duijvestein, M.(4);Buskens, C.(1);Vignali, A.(2);Bemelman, W.(1);
Created: Friday, 14 July 2023, 10:48 AM
P196: Patients with ulcerative colitis (UC) and concomitant primary sclerosing cholangitis (PSC) have more subclinical endoscopic and histologic disease activity in the right colon compared to UC patients without PSC
Year: 2017
Source: ECCO '17 Barcelona
Authors:

Krugliak Cleveland N.1, Rubin D.1, Meckel K.1, Tran A.1, Aelvoet A.1, Gonsalves A.1, Gaetano J.N.2, Williams K.1, Jabri B.1, Wroblewski K.3, Pekow J.*1

Created: Wednesday, 20 February 2019, 10:36 AM
P196: Pre-treatment antibodies to infliximab and adalimumab are common but are not associated with anti-TNF treatment failure
Year: 2022
Source: ECCO'22
Authors: Nice, R.(1,2);Goodhand, J.R.(2,3);Kennedy, N.(2,3);Ahmad, T.(2,3);Winyard, P.(2);McDonald, T.J.(1,2);
Created: Friday, 11 February 2022, 3:52 PM
P196: Risk of venous thromboembolism according to disease activity, hospitalisation, or surgry in inflammatory bowel disease: a nationwide cohort study
Year: 2019
Source:

ECCO '19 Copenhagen

Authors:

T. J. Kim*1, S. M. Kong1, J. B. Shin1, E. R. Kim1, S. N. Hong1, D. K. Chang1, Y-H. Kim1

Created: Friday, 22 February 2019, 9:41 AM
P196: Serum biomarkers reflecting tissue-remodelling correlates with the simple endoscopic score for Crohn’s disease
Year: 2018
Source: ECCO '18 Vienna
Authors:

J.H. Mortensen1*, M.L. Olesen1,2, T. Manon-Jensen1, M.A. Karsdal1, J. Agnholt3, H. Grønbæk3, A. Dige3

Created: Thursday, 21 February 2019, 9:14 AM
P196: Visceral adiposity, genetic susceptibility, and risk of complications amongst individuals with Crohn’s disease
Year: 2016
Source: ECCO '16 Amsterdam
Authors:

K. van der Sloot*1, 2, 3, D. Bellavance1, K. Gilpin1, K. Stewart1, A. Joshi1, J. Garber1, C. Giallourakis1, V. Yajnik1, A. Ananthakrishnan1, B. Alizadeh3, R. Xavier1, H. Khalili1

Created: Friday, 22 February 2019, 9:49 AM
P197 A snap-shot survey of IBD patients’ at a tertiary centre: a focus on knowledge and willingness to self-manage
Year: 2020
Source:

ECCO'20 Vienna

Authors:

L. DYALL1, N. Kamperidis1, R. Fofaria1, V. Fenech1, T. Tyrrell1, S. Barber2, J. Shah3, S. Randall4, C. Okpeh1, N. Arebi1

Created: Thursday, 30 January 2020, 10:12 AM
P197: A biomarker of early mucosal destruction: Neutrophil-mediated type IV collagen degradation is elevated in patients with Crohn's Disease and Ulcerative Colitis
Year: 2023
Source: ECCO’23 Copenhagen
Authors: Sorokina Alexdóttir, M.(1)*;Pehrsson, M.(1);Karsdal, M.A.(1);Godskesen, L.E.(2);Krag , A.(3);Kjeldsen , J.(2);Mortensen, J.H.(1);
Created: Friday, 14 July 2023, 10:48 AM
P197: Anogenital Crohn’s disease and granulomatosis: A systematic review of epidemiology, clinical manifestations, and treatment
Year: 2022
Source: ECCO'22
Authors: Honap, S.(1);Meade, S.(1);Spencer, A.(2);Pavlidis, P.(1);Luber, R.(1);Calonje, E.(3);Rashid, E.(4);Bunker, C.(5);Lewis, F.(3);Irving, P.(1);
Created: Friday, 11 February 2022, 3:52 PM
P197: Crohn’s disease recurrences after surgery: is there something new?
Year: 2019
Source:

ECCO '19 Copenhagen

Authors:

L. Campanati1, M. Giulii Capponi1, M. Marini*1, M. Lotti1, E. Poiasina1, M. Pisano1, N. Paderno1, N. Allievi1, R. Ragozzino1, A. Indriolo2, A. Lucianetti1

Created: Friday, 22 February 2019, 9:41 AM
P197: Improved maternal and neonatal outcomes in a clinic dedicated to pregnant patients with inflammatory bowel disease
Year: 2017
Source: ECCO '17 Barcelona
Authors:

Shitrit A.B.-G.*1, Koslowsky B.1, Livovsky D.M.1, Goldin E.1, Mazuz B.1, Granovsky-Grisaru S.2

Created: Wednesday, 20 February 2019, 10:36 AM
P197: Incidence and management of immunotherapy-induced colitis in a tertiary melanoma and IBD centre: Clinical practice data
Year: 2018
Source: ECCO '18 Vienna
Authors:

V. Cheung1*, T. Gupta1, M. Payne2, M. Middleton2, O. Brain1

Created: Thursday, 21 February 2019, 9:14 AM
P197: The effect of a positive family history on the phenotype and course of paediatric Inflammatory Bowel Disease
Year: 2021
Source: ECCO'21 Virtual
Authors: Ruban, M.(1);Cohen, S.(1);Yerushalmy-Feler, A.(1);
Created: Wednesday, 2 June 2021, 4:12 PM
P197: Use of 6-thioguanine nucleotide concentration test in the management of patients with Crohn’s disease in Korea
Year: 2016
Source: ECCO '16 Amsterdam
Authors:

T. J. Kim*, J. Lee, E.R. Kim, S. N. Hong, D.K. Chang, Y.-H. Kim

Created: Friday, 22 February 2019, 9:49 AM
P198 Colorectal cancer diagnosis in patients with inflammatory bowel disease in Spain: A room for improvement
Year: 2020
Source:

ECCO'20 Vienna

Authors:

R. Saldana1, C. Savini1, P. Bella Castillo2, I. Vera Mendoza2, P. Nos Mateu3

Created: Thursday, 30 January 2020, 10:12 AM
P198: An inflammatory serum metabolomic signature predicts response to vedolizumab treatment in people with Crohn’s Disease
Year: 2022
Source: ECCO'22
Authors: Radford-Smith, D.(1);Yates, A.(2);Hageman, I.(3);Joustra, V.(3);Li Yim, A.(4);Davids, M.(5);Henneman, P.(4);Hakvoort, T.(6);D'Haens, G.(3);de Jong, W.(6);Anthony, D.(1);Satsangi, J.(7);Probert, F.(2);
Created: Friday, 11 February 2022, 3:52 PM
P198: Are lower levels of faecal calprotectin reassuring in Crohn´s Disease patients?
Year: 2018
Source: ECCO '18 Vienna
Authors:

S. Monteiro1,2,3*, F. Dias de Castro1,2,3, S. Leite1,2,3, M.J. Moreira1,2,3, J. Cotter1,2,3

Created: Thursday, 21 February 2019, 9:14 AM
P198: Dipeptidyl peptidase 4: a strong predictive marker of disease activity and treatment escalation in inflammatory bowel diseases
Year: 2017
Source: ECCO '17 Barcelona
Authors:

Pinto-Lopes P.*1,2, Afonso J.1, Macedo G.3, Magro F.1,3

Created: Wednesday, 20 February 2019, 10:36 AM
P198: Faecal calprotectin level correlates well with balloon-assisted endoscopy and computed tomography enterography findings in small bowel Crohn’s disease
Year: 2016
Source: ECCO '16 Amsterdam
Authors:

T. Arai1, K. Takeuchi*1, A. Yamada1, M. Miyamura1, R. Ishikawa2, Y. Suzuki1

Created: Friday, 22 February 2019, 9:49 AM
P198: Multi-alleles predict primary non-response to infliximab therapies in Crohn’s disease: a simple and practicable model
Year: 2019
Source:

ECCO '19 Copenhagen

Authors:

J. Tang*1, C. Zhang2, X. Wang2, X. Gao1

Created: Friday, 22 February 2019, 9:41 AM